Research Appraisalother

Integrating Real-Time Viable Biofluorescent Particle Counters within Robotic Gloveless Isolators

PDA journal of pharmaceutical science and technologyLong, Noël, Khera, Manny, Lumia, Bobby10 Apr 2026DOI

Clinical Snapshot

75CEBM
Evidence: Moderateother

PICO Framework

P — PopulationAseptic pharmaceutical manufacturing environments for injectable drug production
I — InterventionRobotic gloveless isolators integrated with real-time biofluorescent particle counters (BFPCs)
C — ComparatorConventional environmental monitoring methods using active air sampling and culture-based detection
O — OutcomesParticle detection capability, contamination prevention, false positive rates during dynamic and static operating conditions

Bottom Line

This technology validation study demonstrates the successful integration of real-time biofluorescent particle counters within robotic gloveless isolators for pharmaceutical aseptic processing. The research addresses a critical gap in current environmental monitoring, which relies on outdated culture-based methods that cannot provide immediate feedback during manufacturing. Computational fluid dynamics studies verified by airflow visualization showed effective contamination prevention during critical operations like tub peeling and stoppering. The system prevented false positives during normal operations, suggesting reliable performance. However, the study lacks detailed statistical analysis and independent validation. While the technology represents a significant advancement in sterility assurance and aligns with evolving regulatory expectations including EU Annex 1, the commercial sponsorship and limited comparative data warrant cautious interpretation. The approach offers promise for enhancing pharmaceutical quality control but requires broader validation studies.

Evidence: Moderate

Key Findings

  • P Value: Not reported

  • Effect Size: Not quantified in abstract

  • Primary Outcome: Successful integration of BFPCs in robotic gloveless isolators with effective contamination prevention

  • Nnt Or Sensitivity: Prevention of false positives during normal operations, no detectable particles during stoppering process

  • Confidence Interval: Not reported

Clinical Application

High for facilities with resources to invest in advanced isolator technology and real-time monitoring systems Relevant to TGA-regulated pharmaceutical manufacturing facilities. Technology aligns with international harmonization trends and may support compliance with evolving sterility assurance requirements Pharmaceutical manufacturers producing sterile injectable products requiring aseptic processing

Abstract

Advanced technologies in both aseptic filling and environmental monitoring are coming together to improve the resilience and sterility assurance of aseptic processing. Continuous, real-time environmental monitoring using biofluorescent particle counters (BFPCs) to detect viable and nonviable particles during the aseptic filling process for injectable drugs is gaining traction as an accepted alternative to conventional methods such as active air sampling instruments. Evolving regulatory guidance, including EU Annex 1 guidelines, are increasingly recommending the adoption of isolator technology as well as continuous environmental monitoring during GMP processes, including technologies that offer real-time feedback during drug product manufacturing. Computational flow dynamics and airflow visualization studies are additional tools that support the design of equipment and determination of locations for environmental monitoring. The current nutrient culture media growth-based environmental monitoring, rooted in science from 150 years ago, is unable to keep pace with recent technological advances and the ability to immediately react to an out-of-control state. Here we examine the design of an isolator that eliminates human intervention and indirect product contact parts during aseptic fill finish operations and present computational fluid dynamics (CFD) studies verified by airflow visualization, along with the incorporation of BFPCs at critical areas. Also, we report the results of the interference study characterizing the baseline results for detection of total particles (nonviable plus viable) using a BFPC within a robotic gloveless isolator during dynamic and static operating conditions. The results of our study using BFPCs demonstrate that airflow in the robotic gloveless isolator provides protection of critical areas from contamination during the tub peeling process, and that the stoppering process in this environment does not generate detectable particles. During dynamic conditions and material transfer, the study demonstrates the design of the robotic gloveless isolator prevents false positives from interfering with materials during normal operations.

References

  1. 1.Long, N., Khera, M., & Lumia, B. (2026). Integrating Real-Time Viable Biofluorescent Particle Counters within Robotic Gloveless Isolators. PDA Journal of Pharmaceutical Science and Technology. https://doi.org/10.5731/pdajpst.2025-000032.1
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service